Sometimes they come back—the return of influenza  by Cornaglia, G. & Raoult, D.
Sometimes they come back—the return of influenza
G. Cornaglia and D. Raoult
Urmite, UMR CNRS 6236, IRD 198 Universite´ de la Me`diterranee, Faculte´ de Medecine 27, Bd Jean Moulin, 13005, Marseille, France.
E-mail: cmi.raoult@gmail.com
Article published online: 31 December 2010
H1N1 influenza virus in the 2009–2010 season evaded fore-
casts, schemes and plans for intervention, and showed how
any attempt at modelling and prediction on an unknown
influenza variant is futile [1]. In fact, for reasons that are
poorly understood, viral interference of the H1N1 influenza
virus appears to have somehow prevented the emergence of
a ‘regular’ seasonal influenza across Europe in 2010, as con-
firmed by a decrease in the number of hospitalized cases of
influenza during the first trimester of 2010. In the virology
laboratory in Marseille, the number of diagnosed cases of
influenza decreased very significantly in 2010 as compared
with 2009, 2008 and 2007.
Finally, in 2009–2010, H1N1 influenza showed the peculiar
characteristic of stopping at the time of the arrival of the
winter cold, as opposed to usual seasonal influenza, which
owes its very name to its association with winter cold (from
the Italian ‘influenza di freddo’, or ‘influence of the cold’).
The catastrophic predictions of a new ‘Spanish flu’ did not
match the reality observed in 2009–2010. The whole pan-
demic was not so dramatic, although in countries with
impaired public health systems and in immune-impaired
patients, such as preterm babies, pregnant women, and other
vulnerable groups (such as obese and asthmatics), the symp-
toms were more severe and the impact was greater.
The lack of visible effects and poor communication led
most people into mistrusting scientists and to not accept
vaccination. As a result, immunization coverage is very low
in many European countries, and this includes healthcare staff
[2].
According to the WHO influenza update, issued on 17
December (http://www.who.int/csr/disease/influenza/2010
_12_17_GIP_surveillance/en/index.html), increasing reports
from at least 13 countries across the European region indi-
cate the start of wintertime influenza epidemics.
In England, the winter influenza epidemic is under way,
with increasing proportions of specimens testing positive for
influenza virus (56% in England during the second week of
December, of which 67% were H1N1 virus (2009) and 33%
were influenza B virus), and increasing numbers of
severe influenza cases requiring intensive care (http://
www.who.int/csr/disease/influenza/2010_12_17_GIP_surveil
lance/en/index.html). According to the English press, the
number of patients in intensive care has doubled weekly, and
many of them belong to at-risk categories such as elderly or
pregnant patients.
Should the current trend be confirmed, the return of
H1N1 would certainly be a matter for general concern. An
even greater concern would arise in the case of populations
who are less protected by vaccination, such as those in
southern and eastern Europe, and it might pose significant
problems with serious influenza forms like those being
observed in England. Interestingly enough, during the first
week of December 2010, two such countries, namely the
Russian Federation and Ukraine, have already reported
levels of influenza-like illness above the seasonal baseline
(http://www.who.int/csr/disease/influenza/2010_12_17_GIP_
surveillance/en/index.html).
The current re-emergence of influenza has come as a sur-
prise to many people, mostly if one considers the low influ-
enza activity recently recorded in the southern hemisphere,
where, however, both influenza incidence and vaccination
rates in 2009–2010 had been higher than in Europe, certainly
leading to more generalized immunization.
The British Medical Association has warned that the out-
break could be much more serious this year because fewer
people are being vaccinated, and has appealed to the govern-
ment to step up the influenza public awareness campaign,
admitting that ‘many patients have concerns about the H1N1
component of this year’s seasonal flu vaccination and for this
reason they are choosing to opt out’ and advocating ‘a con-
certed campaign to highlight the safety and effectiveness of
flu jabs, and the risks of opting-out’ (http://web2.bma.org.uk/
pressrel.nsf/wlu/SGOY-8C8FDV?OpenDocument).
The question of a resumption of emergency vaccination
therefore arises, and we consider it a priority for public
health in Europe. We strongly believe that promotion of the
vaccine should be improved and that information should be
promptly organized and structured far better than it was
1 year ago. It is noteworthy that all influenza A H1N1
(2009) viruses characterized to date, in samples from the
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community, hospitalized patients and fatal cases in the UK,
are antigenically homogeneous and similar to the vaccine
virus A/California/7/2009 (http://www.who.int/csr/disease/
influenza/2010_12_17_GIP_surveillance/en/index.html).
In 2009–2010, poor communication led to people not
trusting scientists and public health officers, let alone politi-
cians, and many did not get vaccinated. The apparent lack of
serious consequences reinforced people’s belief that vaccina-
tion was not needed (and, according to many, even harmful).
Now the consequences of non-vaccination, i.e. the return of
influenza striking a non-immune population and the risk of
igniting a new ‘emergence of influenza’ raises the question of
whether people will finally be convinced or will retain their
anti-vaccine attitude. This time, the consequences might well
pass the visibility threshold and show that the dramatic fore-
casts of 2009–2010 were only wrong with regard to their
timing.
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